John Tyhonas

745 total citations
14 papers, 421 citations indexed

About

John Tyhonas is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, John Tyhonas has authored 14 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Genetics. Recurrent topics in John Tyhonas's work include Fibroblast Growth Factor Research (3 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). John Tyhonas is often cited by papers focused on Fibroblast Growth Factor Research (3 papers), Estrogen and related hormone effects (3 papers) and Retinoids in leukemia and cellular processes (3 papers). John Tyhonas collaborates with scholars based in United States. John Tyhonas's co-authors include Jonathan S. Lindsey, Yao‐Yuan Chuang, Feirong Li, Donald S. Karanewsky, Robert Ardecky, Timothy A. Grese, Pierre‐Yves Michellys, Mark D. Leibowitz, Anne Reifel‐Miller and Deepa Rungta and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

John Tyhonas

14 papers receiving 407 citations

Peers

John Tyhonas

Suk-Yu Wong Hong Kong

G. Rihs Switzerland

Mario Gabričević Croatia

Aloka Srinivasan United States

Dann L. Parker United States

Jean A. Hamilton United States

Jianming Bao United States

Chitra Sundararajan United States

Yutaro Saito Japan

Suk-Yu Wong Hong Kong

John Tyhonas

110 ×0.5

173 ×0.9

122 ×1.0

87 ×1.6

30 ×0.7

Citations per year, relative to John Tyhonas John Tyhonas (= 1×) peers Suk-Yu Wong

Countries citing papers authored by John Tyhonas

Since Specialization

Citations

This map shows the geographic impact of John Tyhonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tyhonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tyhonas more than expected).

Fields of papers citing papers by John Tyhonas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Tyhonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tyhonas. The network helps show where John Tyhonas may publish in the future.

Co-authorship network of co-authors of John Tyhonas

This figure shows the co-authorship network connecting the top 25 collaborators of John Tyhonas. A scholar is included among the top collaborators of John Tyhonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Tyhonas. John Tyhonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chen, Young K., Toufike Kanouni, Lee D. Arnold, et al.. (2024). The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition. Journal of Medicinal Chemistry. 67(3). 1747–1757. 5 indexed citations

Balasooriya, Eranga R., Haley Ellis, Yuanli Zhen, et al.. (2024). The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clinical Cancer Research. 30(10). 2181–2192. 6 indexed citations

Tyhonas, John, Lee D. Arnold, Jason M. Cox, et al.. (2024). Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations. Journal of Medicinal Chemistry. 67(3). 1734–1746. 10 indexed citations

Sabat, M., Luca F. Raveglia, Laura Aldegheri, et al.. (2022). The discovery of (1R, 3R)-1-(3-chloro-5-fluorophenyl)-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonitrile, a potent and selective agonist of human transient receptor potential cation channel subfamily m member 5 (TRPM5) and evaluation of as a potential gastrointestinal prokinetic agent. Bioorganic & Medicinal Chemistry. 76. 117084–117084. 2 indexed citations

Franovic, Aleksandra, Sean Uryu, Qibiao Wu, et al.. (2022). Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations.. Journal of Clinical Oncology. 40(4_suppl). 461–461. 7 indexed citations

Lanier, Marion, Erica L. Bradshaw‐Pierce, Alison Chambers, et al.. (2017). Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure. ACS Medicinal Chemistry Letters. 8(3). 316–320. 33 indexed citations

Ardecky, Robert, Andrew R. Hudson, Dean P. Phillips, et al.. (2007). 5(Z)-Benzylidene-1,2-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5H-1-aza-6-oxa-chrysenes as non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters. 17(15). 4158–4162. 9 indexed citations

Michellys, Pierre‐Yves, Marcus F. Boehm, Timothy A. Grese, et al.. (2003). Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 13(22). 4071–4075. 21 indexed citations

Gernert, Douglas L., Rose T. Ajamie, Mike Bell, et al.. (2003). Design and synthesis of fluorinated RXR modulators. Bioorganic & Medicinal Chemistry Letters. 13(19). 3191–3195. 16 indexed citations

10.

Michellys, Pierre‐Yves, Robert Ardecky, Timothy A. Grese, et al.. (2003). Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids. Journal of Medicinal Chemistry. 46(19). 4087–4103. 25 indexed citations

11.

Brooks, Dawn A., Garret J. Etgen, Christopher J. Rito, et al.. (2001). Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ Agonists. Journal of Medicinal Chemistry. 44(13). 2061–2064. 56 indexed citations

12.

Ravikanth, Mangalampalli, Catalina Achim, John Tyhonas, Eckard Münck, & Jonathan S. Lindsey. (1997). Investigation of Phthalocyanine Catalysts for the Aerobic Synthesis of meso-Substituted Porphyrins. Journal of Porphyrins and Phthalocyanines. 1(4). 385–394. 15 indexed citations

13.

Li, Feirong, et al.. (1997). Beneficial effects of salts on an acid-catalyzed condensation leading to porphyrin formation. Tetrahedron. 53(37). 12339–12360. 96 indexed citations

14.

Lindsey, Jonathan S., et al.. (1994). Investigation of a Synthesis of meso-Porphyrins Employing High Concentration Conditions and an Electron Transport Chain for Aerobic Oxidation. The Journal of Organic Chemistry. 59(3). 579–587. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact